Tissue injury that accompanies hypoxemia/reoxygenation shares features with the host response in inflammation, suggesting that cytokines, such as IL-1, may act as mediators in this setting. Human endothelial cells (ECs) subjected to hypoxia (PO2 approximately 12-14 Torr) elaborated IL-1 activity into conditioned media in a time-dependent manner; this activity was completely neutralized by an antibody to IL-1 alpha. Production of IL-1 activity by hypoxic ECs was associated with an increase in the level of mRNA for IL-1 alpha, and was followed by induction of endothelial-leukocyte adhesion molecule-1 and enhanced expression of intercellular adhesion molecule-1 (ICAM-1) during reoxygenation. During reoxygenation there was a three-to five-fold increased adherence of leukocytes, partly blocked by antibodies to endothelial-leukocyte adhesion molecule-1 and ICAM-1. Suppressing endothelial-derived IL-1, using either antibodies to IL-1 alpha, specific antisense oligonucleotides or the IL-1 receptor antagonist, decreased leukocyte adherence to reoxygenated ECs, emphasizing the integral role of IL-1 in the adherence phenomenon. Mice subjected to hypoxia (PO2 approximately 30-40 Torr) displayed increased plasma levels of IL-1 alpha, induction of IL-1 alpha mRNA in the lung, and enhanced expression of ICAM-1 in pulmonary tissue compared with normoxic controls. These data suggest that hypoxia is a stimulus which induces EC synthesis and release of IL-1 alpha, resulting in an autocrine enhancement in the expression of adhesion molecules.
Introduction
Recent work has focused attention on the role of leukocytes and other inflammatory cells in the tissue damage which occurs in ischemic syndromes (1) (2) (3) (4) (5) . Cytokines, such as IL- 1 and tumor necrosis factor, play a key role in mediating the host inflammatory response, and are likely candidates to draw leukocytes to loci of hypoxic vascular injury. This response could occur via the increased expression ofleukocyte adherence mole-1992. cules on the surface of endothelial cells (ECs)' (6-1 1 ), as well as through elaboration ofchemoattractant substances ( 12, 13) .
Cultured ECs have been shown to elaborate IL-1, as well as other cytokines, in response to pathophysiologically relevant stimuli such as lipopolysaccharides and thrombin (14) (15) (16) . This led us to test the hypothesis that hypoxia could induce EC production of IL-1, resulting in autocrine enhancement in the expression of adhesion molecules thereby increasing leukocyte binding to the vessel surface. Our results indicate that hypoxia induces an increase in IL-1 mRNA, and release of active IL-1 a by cultured endothelium. IL-1, thus produced, results in induction of endothelial-leukocyte adhesion molecule-1 (ELAM-1) and increased expression of intercellular adhesion molecule-1 (ICAM-1 ) on ECs. In addition, IL-1 a mRNA is induced in the lungs of mice subjected to hypoxia, after which ICAM-1 antigen is expressed at considerably higher levels than in normoxic controls. Taken together, these results support the hypothesis that cytokine production by hypoxic ECs can contribute to the host response in the pathogenesis of ischemic vascular injury.
Methods
Endothelial cell culture and exposure of cells to hypoxia/reoxygenation. Human umbilical vein ECs were prepared from umbilical cords and grown in culture by the method of Jaffe ( 17) as modified by Thornton ( 18 ) . Experiments used confluent ECs (passages 1-4) grown in Medium 199 supplemented with fetal bovine serum (10%; Sterile Systems, Logan, UT), recombinant endothelial cell growth factor (8 ng/ml; obtained from Dr. T. Maciag and processed at Hoffmann-LaRoche Inc., Nutley, NJ), heparin (90 Atg/ml; Sigma Chemical Co., St.
Louis, MO), and antibiotics. For experiments with sense/antisense oligonucleotides for IL-la (the latter designed to bind nine nucleotides upstream and downstream from the translation initiation codon of IL-la), as described ( 19) , oligomers were added to EC cultures daily (10 ,M, final concentration). When ECs achieved confluence, experiments were performed by placing cultures in an environmental chamber (Coy Laboratory Products, Ann Arbor, MI), which provides a controlled atmosphere containing the indicated amount of oxygen, carbon dioxide (5%), with the balance made up of nitrogen. Use ofthis chamber for cell culture experiments has been described previously by Ogawa et al. (20) . Temperature was maintained at 37°C. Experiments involved exposure of ECs to hypoxia for a maximum of 24 h, during which time oxygen tension in the culture medium was 12-14 Torr and there was no change in medium pH. Reoxygenation was performed by placing ECs in an ambient air atmosphere containing carbon dioxide (5%) at 37°C.
Endothelial cell-leukocyte interaction. The source of leukocytes was either HL60 cells obtained from American Type Culture Collec-tion, Rockville, MD, and grown in RPMI 1640 (Gibco Laboratories, Grand Island, NY) supplemented with fetal calfserum ( l0%) orperipheral blood leukocytes. For the latter, blood was collected from healthy donors by venipuncture in syringes containing EDTA (5 mM final concentration), diluted 1:1 with NaCl (0.9%), and separated by gradient centrifugation on Ficoll Hypaque (Pharmacia LKB Biotechnology Inc., Piscataway, NJ) as described (21 ) . ECs grown to confluence in 100-mm dishes were either exposed to normoxia, placed in hypoxia (Po2 12-14 Torr) or subjected to hypoxia followed by a period of replacement into normoxia (reoxygenation), as indicated. Cultures were then washed once with RPMI 1640 and incubated with either HL60 cells or leukocytes (2 X 106 cells/ml) for 30 min at 250C in hypoxia or normoxia as indicated. The binding experiment was terminated by washing monolayers twice with cold RPMI 1640 to remove nonadherent cells, and then leukocytes or HL60 cells adherent to ECs were eluted by addition of 1 ml of EDTA ( 10 mM) for 2 min at 370C. Under these conditions the EC monolayer remained intact. Detached cells were counted; three separate aliquots per sample, in a hemocytometer, and post hoc comparisons of individual means were performed using the Tukey test for certain binding data. All binding assays were performed in an atmosphere with the indicated oxygen concentration. Assays ofIL-1. IL-I activity was detected using the DO assay (24), murine IL-1 a antigen was assessed by radioimmunoassay, and changes in expression of IL-1 a mRNA were studied by polymerase chain reaction (PCR). For the activity assay, serum-free supernatants that had been centrifuged and filtered (0.2 gm) to remove cellular debris were incubated with the D1O(N4)M cell line (24) , and mitogenesis was assessed. The limit of sensitivity in this assay was 2 U/ml. IL-l activity in samples from hypoxic ECs was neutralized by the IgG fraction derived from a monospecific goat anti-human IL-la. Murine IL-la antigen was measured in mouse plasma using a radioimmunoassay kit from Cytokine Sciences, Inc. (Boston, MA) according to the manufacturer's instructions (limit of detection 20-30 pg/ml). For PCR, cultured ECs were exposed to normoxia, hypoxia, or hypoxia/reoxygenation, total RNA was extracted using the acid-guanidinium hydrochloride procedure (Stratagene Inc., La Jolla, CA). Random hexanucleotide primed first strand cDNA was prepared and served as template for PCR analysis. IL-la primers were those described by Maier et al. ( 19) , and glyceraldehyde-6-phosphate dehydrogenase (GAPDH) primers were 5' CCA TGG AGA AGG CTG GGG 3' (sense) and 5' CAA ATG TGT CAT GGA TGA CC 3' (antisense). For positive controls, 10 ng of plasmid carrying either IL-la or GAPDH cDNA sequences were used. cDNA was amplified by PCR for 35 cycles, each cycle consisting of incubations at 940C for 1 min, 550C for 2 min, and 720C for 3 min. Products were analyzed by agarose gel electrophoresis (2%) and were visualized with ethidium bromide under ultraviolet light, transferred to nylon membranes and Southern hybridization performed using 32P-labeled cDNA encoding full-length human IL-la. PCR on samples derived from hypoxic mouse lung tissue was performed as described as above, except that primers for murine IL-1 a were obtained from Clontech Laboratories, Inc. (Palo Alto, CA).
Southern hybridization was similarly performed on these samples using 32P-labeled cDNA encoding full-length mouse IL-la. After washing, the filter was analyzed in a /3-scanner to compare bands in hypoxia (8 and 2 h) and normoxia ( Fig. 4 a, panel B) . In control studies, the same cDNA (derived from lung) was amplified with the human GAPDH primers described above, except that the primer annealing temperature was dropped to 50°C. The hatched bars indicate culture supernatants prepared identically, but assayed in the presence of anti-IL-la IgG (2.5 ,ug/ml Exposure ofmice to hypoxia and immunohistology. Mice were subjected to hypoxic conditions and reoxygenated using a controlled environment chamber (access to this chamber was generously provided by Dr. R. Stark, Dept. of Pediatrics, Columbia University). The chamber was equipped with circulating fans, and inflow and outflow valves (Skinner valves; Honeywell Inc., New Britain, CT) connected to a microprocessor and instantaneous on-line oxygen sensor (Horiba Ltd., Kyoto, Japan). This apparatus controlled the flow of the gas mixture and a one way outflow valve was used to maintain the pressure at atmospheric levels. The environment within the chamber was continuously regulated by a custom built interface (K + K Interface Inc., NY) and utilized an environmental control program (K + M) running on an XT clone microprocessor equipped with a Megaboard logic board (Display Telecommunications Corp., Dallas, TX) and an analogue to digital conversion package (LabMaster Scientific Solutions Inc., Solon, OH). The temperature and humidity in the chamber were at room ambient environment, and were also controlled by the automated system above. Mice were placed in the chamber in their usual cages and allowed free access to food and water, and the system parameters were adjusted to a final oxygen concentration of 8-10% with the balance of the gas mixture being made up of nitrogen. Over the first hour, the oxygen content of the atmosphere was reduced from ambient levels to 15%, and over the second hour, it was reduced to 8-10%. Mice were exposed to hypoxia for varying times, plasma samples were obtained, and lung tissue collected for extraction of RNA (see above) and for immunohistology. Tissue was fixed in paraformaldehyde (3.5%) and embedded in paraffin. Sections were stained for ICAM-I using a specific rat anti-mouse ICAM-l monoclonal antibody YN. 1, obtained from American Type Culture Collection. Sites of primary antibody binding were visualized with a peroxidase-coupled secondary antibody.
Results IL-I production by hypoxic ECs. When cultured ECs were exposed to hypoxia, they elaborated IL-I into the conditioned medium in a time-dependent manner, with levels peaking after 16 h ofhypoxia, as measured in the D 10 assay. This IL-I activity was neutralized by an antibody to IL-1 a, bringing the activity down to the baseline (Fig. 1 a) . IL-l released by hypoxic ECs was not a consequence of cell death, as cellular viability after 16-22 h of exposure to hypoxia remained unaffected, as assessed by several criteria: ECs remained adherent to the surface as a confluent monolayer, excluded trypan blue, and demonstrated only a reversible 20-30% decrease in general protein synthesis (25) . Consistent with the specificity of hypoxia as a stimulus for the induction of IL-1, no elaboration of IL-1 by ECs was observed during reoxygenation (data not shown).
In parallel with the increase of IL-1 a activity in the culture (Fig. 1 b, panel  A) . Southern blots of these amplicons, hybridized to a cDNA encoding full-length IL-la, showed strong induction of IL-I a in the hypoxic samples. (Fig. 1 b, panel B) . Amplification of mRNA for GAPDH demonstrated that levels of transcript for this constitutive enzyme were unaffected by hypoxia (Fig. 1 b,  panel B) , confirming selective induction of IL-1a mRNA. Enhanced leukocyte-EC adherence and increased expression ofendothelial cell surface adherence molecules during hypoxia/reoxygenation. Despite the presence of IL-1 in the supernatant of hypoxic ECs, cultures exposed only to hypoxia demonstrated 50% decreased adherence ofHL60 cells compared with normoxic controls (Fig. 2 a) . In contrast, reoxygenated ECs showed a three-to fivefold enhancement in HL60 cell binding compared with normoxia. Increased binding of HL60 cells to reoxygenated ECs could be inhibited by 50% using antibodies to either ELAM-l or ICAM-l (Fig. 2 b) . Addition ofexogenous IL-1 a to normoxic EC cultures, in amounts similar to that detected in the medium of hypoxic EC, led to increases in HL60 adherence in the range ofthose detected in Fig.  2 a. Experiments with PMNs in place of HL60 cells showed similarly enhanced adherence of reoxygenated ECs (data not shown).
Consistent with a role for ELAM-1 and ICAM-1 in the binding ofleukocytes to reoxygenated ECs, Western blot analysis demonstrated upregulation ofthese cell adhesion molecules when hypoxic cultures were restored to normoxia (Fig. 2 c) . ELAM-1 antigen was induced by 4 h of reoxygenation, and declined to nondetectable levels 24 h later. ICAM-1, constitutively present in cultured ECs (6, 7) , demonstrated an increase in expression by 4 h of reoxygenation which persisted through 24 h. ECs exposed to hypoxia alone did not display increased levels of either ELAM-1 or ICAM-1 (data not shown).
The central contribution ofendothelial-derived IL-I in enhanced adherence ofleukocytes to EC cultures subjected to hypoxia/reoxygenation. The data obtained thus far supported the hypothesis that IL-1 produced by ECs during hypoxia was the mediator of enhanced expression of adhesion molecules and increased leukocyte binding during reoxygenation. To test this, the effect of inhibitors of IL-1 translation and IL-1-receptor interaction was assessed (Fig. 3 a) . Antibody to IL-lIa, added to hypoxic EC monolayers before reoxygenation blocked HL60 cell binding during reoxygenation by about 60%, whereas an irrelevant antibody to (coagulation Factor IX) had no effect. Antisense oligonucleotides, used to suppress selectively translation of IL-1 a protein ( 19) , similarly suppressed the reoxygenation-associated increase in HL60 adhesion (elaboration of IL-I activity by endothelial cultures in hypoxia was suppressed by antisense IL-1 oligonucleotides, data not shown). Sense oligonucleotides for IL-1a were without effect. Addition of recombinant IL-1RA to hypoxic ECs resulted in marked depression of HL60 cell adhesion by 70-75% during reoxygenation.
To explain the apparent paradox that IL-1 was produced in hypoxia, while the EC response to IL-1 occurred during reoxygenation, we considered whether hypoxic endothelial cultures were capable of responding to exogenous IL-I (Fig. 3 b) . Addition of exogenous IL-la (55 pg/ml or 83 U/ml, and 1 10 pg/ ml or 166 U/ml) to then either goat anti-IL-Ia IgG (10 Atg/ml), goat anti-bovine Factor IX IgG ( 10 ug/ml), or IL-1 receptor antagonist (IL-IRA) ( 1 ag/ml) was added just before reoxygenation. Cultures were then maintained for 4 h in an atmosphere with ambient oxygen tension. Other EC cultures were grown to confluence in the presence of sense and antisense oligonucleotides to IL-I a. Oligomers were added to a final concentration of 10 ,uM daily and just before reoxygenation. 4 (Fig. 4 a, panel A) . Southern hybridization of these PCR tissue culture to the in vivo setting, mice were exposed to hyp-products with a cDNA encoding full-length murine IL-lIa demoxia (Po2 _-30-40 Torr) and production of IL-I was assessed. onstrated an increase in the level of IL-lIa n)RNA in hypoxia, PCR analysis of RNA from hypoxic mouse lungs demoncompared with the low levels detectable in normoxic controls Endothelium and Hypoxia 2337 (Fig. 4 a, panel B) . 13-scanning demonstrated an approximately seven-fold increase in the signal in the hypoxic lane (Fig. 4 a,  panel B, H8 ). The same samples showed equal levels of GAPDH transcripts (Fig. 4 a, panel C) . Consistent with these results, IL-la antigen levels in mouse plasma reached a peak 8-12 h after exposure to hypoxia (Fig. 4 b) . Probable evidence ofthe action ofIL-1 in vivo was seen in the positive staining for ICAM-1 on pulmonary endothelium of small veins, venules, and lymphatics, as well as the structures of the alveolar wall (Fig. 4 c, panels I-IV) , which occurred in hypoxic animals 4 h after peak plasma levels of the cytokine, consistent with the patterns of staining in injured lungs as previously reported (26) . An example of intense staining of alveolar elements for ICAM-1 in the hypoxic lung is seen at high resolution in Fig. 4 c, panel IV(compare with normoxic lung, Fig. 4 c, panel II) .
Discussion
These studies show that exposure of vascular endothelium to hypoxia results in the production of IL-1 a: both the level of mRNA for IL-1a and IL-1a activity increase. Studies by Schindler et al. (27) ofIL-1 production in mononuclear phagocytes have demonstrated a dissociation between levels of IL-1# mRNA and synthesis of the protein with respect to certain stimuli such as C5a or adherence of cells to a substrate. In contrast, hypoxia appears to represent a different type ofstimulus for ECs, coordinately inducing IL-1 a at the message and protein levels. This result parallels the effect of lipopolysaccharide on IL-1: in the macrophage (28) . Although the mechanisms of IL-1 a release in hypoxia, as well as other conditions, remain to be elucidated, alterations in cell viability do not appear to be involved. The period of hypoxia used in our experiments did not lead to cell death; rather, cells remained intact and were reversibly stimulated to produce IL-1. After reoxygenation, EC IL-1 production decreased to the baseline, and cells could be further subcultured.
IL-1a produced by ECs during the period of hypoxia appeared to have its major effect on induction of leukocyte adhesion molecules during reoxygenation. This effect was most likely caused by a blunted cellular response to IL-1 during hypoxia, perhaps consequent to attenuated protein synthesis in an atmosphere with low oxygen concentrations (26) . Even longer incubations of ECs in hypoxia (20-24 h) did not result in expression of ELAM-1 or ICAM-1, whereas 16 h of hypoxia followed by reoxygenation led to production of these adhesion molecules within 4 h. Thus, a period ofhypoxia was necessary, but not sufficient, for enhanced expression of ELAM-1 and ICAM-1 by cultured ECs. Our observations are consistent with the results of Yoshida et al. (29), who demonstrated increased CD 11 / 18-mediated leukocyte adhesion to cultured ECs exposed to anoxia during the reoxygenation period. In contrast to these results in cell culture, increased expression of ICAM-1 was seen in the lungs of hypoxic mice, suggesting that higher local concentrations of IL-1 or other factors in the in vivo milieu facilitated endothelial production of adhesion molecules. These data support observations in other studies ( 1, 2) which show that blocking leukocyte-endothelial interactions decreases vascular and tissue injury in ischemia reperfusion.
Although multiple issues remain to be clarified with respect to the production of IL-1 a by hypoxic ECs, such as the relative contribution of membrane-associated IL-1 versus IL-1 elaborated into the culture supernatant, this phenomenon represents a potentially important autocrine mechanism through which vascular ECs can alter their adhesive properties, thereby promoting leukocyte adherence to sites of hypoxemic vessel wall injury. The significance of this mechanism is emphasized by our recent pilot studies indicating that IL-8 is also produced by hypoxic ECs, suggesting the possibility that hypoxia not only alters EC-leukocyte adherence, but may also increase leukocyte migration. Thus, hypoxia constitutes an activating stimulus for the endothelium, priming the vessel surface for enhanced leukocyte interactions.
